Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials
about
Post-surgical chemotherapy versus surgery alone for resectable gastric cancerNeoadjuvant or adjuvant therapy for gastric cancerAntibacterial Activity of Essential Oils and Their Isolated Constituents against Cariogenic Bacteria: A Systematic ReviewScreening and identification of mimotope of gastric cancer associated antigen MGb1-Ag.Stable transfection of extrinsic Smac gene enhances apoptosis-inducing effects of chemotherapeutic drugs on gastric cancer cells.Adjuvant FOLFOX-4 in patients with radically resected gastric cancer: Tolerability and prognostic factors.Docetaxel, cisplatin and fluorouracil (DCF) regimen compared with non-taxane-containing palliative chemotherapy for gastric carcinoma: a systematic review and meta-analysisTreatment of resectable gastric cancer.Treatment of peritoneal carcinomatosis in gastric cancers.Perioperative adjunctive treatment in the management of operable gastric cancer.Catheterization-associated complications of intraperitoneal chemotherapy in advanced gastric cancer.Evidence-based recommendations for local-regional control of gastric cancer.Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2'-deoxyuridineReview of capecitabine as oral treatment of gastric, gastroesophageal, and esophageal cancers.Reflections on adjuvant treatment of gastric cancer.Advances in the treatment of patients with gastric adenocarcinoma.Pharmacotherapy for oesophagogastric cancer.The role of postoperative adjuvant chemotherapy following curative resection for gastric cancer: a meta-analysis.Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patientsMeta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer.Adjuvant treatment combining cellular immunotherapy with chemotherapy improves the clinical outcome of patients with stage II/III gastric cancerNeoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America.Randomized trials and quality assurance in gastric cancer surgery.Quality of care indicators for the surgical treatment of gastric cancer: a systematic review.Perioperative chemotherapy in locally advanced gastric cancer.Detection of micrometastasis of gastric carcinoma in peripheral blood circulationR0 resection in the treatment of gastric cancer: room for improvement.Neoadjuvant plus adjuvant chemotherapy benefits overall survival of locally advanced gastric cancer.HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy.Validity of studies suggesting postsurgical chemotherapy for resectable gastric cancer: critical appraisal of randomised trials.Four consecutive multicenter phase II trials of adjuvant chemoradiation in patients with completely resected high-risk gastric cancer: the experience of the German AIO/ARO/CAO group.Adjuvant endocrine monotherapy for postmenopausal early breast cancer patients with hormone-receptor positive: a systemic review and network meta-analysis.Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer.
P2860
Q24198252-7DAF8D40-E461-4DB4-BED8-597B4231D0BEQ26797427-6F3B0B72-ECDC-4894-97D4-06D3D4942293Q28261149-CD714CDD-425A-44DB-B681-6C341D3CA2F9Q31156798-C0341786-AAE9-4FAE-B08D-8FE339D3293DQ33210192-BFFBBBFF-22B0-4221-9B53-11C4F7FB415CQ33403424-2191F19D-6194-4C69-8A87-60F357EC774DQ34672942-E418D6D1-E8BA-4B94-8E0F-B0F9F8771172Q35688584-96D3B368-937A-45DC-A4BF-9885C11EDCBBQ36090050-91809B92-AE50-46B2-B07F-DF188B8579A5Q36128331-D00F8910-7070-47E2-A788-0F453BC74FD6Q36213882-E2ADA456-AE5B-4300-B4DE-C67700235EA6Q36229753-3EA2EDAD-B481-4378-A36A-936A3DDC96E9Q36474351-0DA415C5-7381-4222-9DA9-E4DB4514307AQ36505106-43420F1D-9B98-4C6A-90A4-F0569A0AF718Q36642921-8845A01F-4A32-4320-8DBC-53A579897CE8Q36798382-094CC60F-BB89-49A7-95D5-B3C8AE50A517Q37011966-9A84CFB7-5D65-4B28-83B2-438A2954CD4BQ37101403-D4B45075-B9C0-46D4-9D9C-EBAFB329FCFCQ37135262-143D3402-DACE-45EC-ADB4-C133346D7112Q37328181-289D7D19-937A-49D2-8905-2AD7604FA8CBQ37609431-BAD4DB8D-8B3A-4CC0-9E83-3CA14580E73AQ37998931-E9FFAB4D-1E27-466B-A1F2-4E1E25E475D5Q38001383-3546D8C2-F971-46DF-97F1-8FB60E2F482CQ38051100-C6501D43-1051-42EA-83C0-A673FB8FBFDBQ38169894-DF5FCB6D-C2D4-4DA5-807E-CDAD927EBCEAQ42004654-62B3E430-E8D3-4DB3-9398-124E9A1FFC77Q42732352-31F8A956-1E05-4064-979B-B4E2527515C0Q42971706-DBEF3B1D-AF37-48A1-9EB8-35D77CA51863Q43216188-B4EA251D-0B7E-4841-9058-4CE96809EC5CQ45197627-85EE2479-38C0-4543-B27F-2836172CB347Q46339959-3D1BD57E-CEC7-4715-AF93-49DCF3B68E6CQ47100249-04287329-0F46-435C-932B-B43AA5C9FDFAQ54571851-61CCCFAC-F6A6-4558-ACDE-65A4A6FC4D5F
P2860
Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Intravenous chemotherapy for r ...... f randomized controlled trials
@ast
Intravenous chemotherapy for r ...... f randomized controlled trials
@en
type
label
Intravenous chemotherapy for r ...... f randomized controlled trials
@ast
Intravenous chemotherapy for r ...... f randomized controlled trials
@en
prefLabel
Intravenous chemotherapy for r ...... f randomized controlled trials
@ast
Intravenous chemotherapy for r ...... f randomized controlled trials
@en
P2093
P2860
P356
P1476
Intravenous chemotherapy for r ...... f randomized controlled trials
@en
P2093
Chao-Hua Wang
Hong-Yan Chen
Jia-Ping Chen
Jian-Kun Hu
You-Ping Li
Zhi-Xin Chen
Zong-Guang Zhou
P2860
P304
P356
10.3748/WJG.V8.I6.1023
P407
P577
2002-12-01T00:00:00Z